Scarica l'app Stockscreener
21.33
7.62%
-1.76
Dopo l'orario di chiusura:
20.90
-0.43
-2.02%
Precedente Chiudi:
$23.09
Aprire:
$22.55
Volume 24 ore:
3.47M
Relative Volume:
0.77
Capitalizzazione di mercato:
$1.33B
Reddito:
$14.34M
Utile/perdita netta:
$-199.00M
Rapporto P/E:
-5.4413
EPS:
-3.92
Flusso di cassa netto:
$-183.51M
1 W Prestazione:
-22.46%
1M Prestazione:
-18.15%
6M Prestazione:
+28.42%
1 anno Prestazione:
+223.67%
Intervallo 1D:
$20.55
$22.98
Intervallo di 1 settimana:
$20.55
$26.95
Portata 52W:
$6.62
$71.50
Uniqure N V Stock (QURE) Company Profile
Nome
Uniqure N V
Settore
Industria
Telefono
1-339-970-7000
Indirizzo
PAASHEUVELWEG 25A, AMSTERDAM
Confronta QURE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
21.33 | 1.42B | 14.34M | -199.00M | -183.51M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-04 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-04-01 | Ripresa | Chardan Capital Markets | Buy |
| 2024-12-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-02-29 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-19 | Downgrade | Mizuho | Buy → Neutral |
| 2022-03-17 | Aggiornamento | UBS | Neutral → Buy |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-21 | Iniziato | UBS | Neutral |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-04-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-11-09 | Iniziato | Jefferies | Buy |
| 2020-11-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-08-25 | Iniziato | Raymond James | Strong Buy |
| 2020-07-31 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | Downgrade | Mizuho | Buy → Neutral |
| 2020-06-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | Iniziato | Cowen | Outperform |
| 2019-12-03 | Iniziato | Goldman | Buy |
| 2019-11-05 | Iniziato | Credit Suisse | Outperform |
| 2019-10-11 | Iniziato | Stifel | Buy |
| 2019-09-25 | Iniziato | Bernstein | Outperform |
| 2019-09-12 | Iniziato | Mizuho | Buy |
| 2019-07-30 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-07-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2019-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-03-29 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Uniqure N V Borsa (QURE) Ultime notizie
Aug Wrap: Can uniQure NV stock surprise with earnings upside2025 Key Highlights & Smart Swing Trading Techniques - BỘ NỘI VỤ
uniQure (NASDAQ:QURE) Shares Down 5.1%Here's What Happened - MarketBeat
QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - Your Wyoming Link
QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
uniQure (NASDAQ:QURE) Receives "Buy" Rating from Chardan Capital - MarketBeat
uniQure (NASDAQ:QURE) Shares Gap DownHere's What Happened - MarketBeat
How uniQure N.V. (UQ1) stock benefits from digital adoptionTrade Ideas & Scalable Portfolio Growth Methods - Newser
How strong is uniQure N.V. stock revenue growthJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - Newser
uniQure (QURE) Is Down 17.3% After FDA Questions AMT-130 Data Sufficiency For BLAHas The Bull Case Changed? - simplywall.st
Chardan Capital Maintains uniQure N.V. (QURE) Buy Recommendation - Nasdaq
uniQure (QURE) Stock: Navigates Regulatory Hurdles for AMT-130 as FDA Requests Further Engagement - parameter.io
uniQure (QURE) Analyst Ratings: Chardan Capital Maintains Buy Ra - GuruFocus
Why uniQure Stock Is Trading Lower After FDA Meeting Update - Benzinga
uniQure N.V. (QURE): A Bear Case Theory - Finviz
uniQure (QURE) Shares Plunge 20% on FDA Feedback for AMT-130 - GuruFocus
uniQure says FDA announced Phase I/II AMT-130 data unlikely to support BLA - TipRanks
UniQure stock falls after FDA's notes on pre-application of AMT-130 - MSN
uniQure stock falls after FDA's notes on pre application of AMT-130 - Seeking Alpha
uniQure stock falls after FDA signals data unlikely to support AMT-130 approval - Investing.com Canada
uniQure (QURE) Reassesses Strategy After FDA Feedback on AMT-130 Application - GuruFocus
UniQure Seeks US FDA Follow-Up Meeting After Being Told Data Do Not Support BLA Submission - marketscreener.com
Why Is UniQure Stock Falling In Pre-market? - Nasdaq
uniQure Faces Setback in Gene Therapy Approval - TipRanks
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease - The Manila Times
uniQure N.V. Provides Regulatory Update on AMT-130 for Huntington's Disease - TradingView
Uniqure N.V. Provides Regulatory Update on Amt-130 for Huntington's Disease - marketscreener.com
uniQure (NASDAQ: QURE) receives FDA minutes on AMT-130 BLA path for Huntington’s disease - Stock Titan
uniQure N.V. $QURE Stake Reduced by Schroder Investment Management Group - MarketBeat
uniQure N.V. $QURE Shares Acquired by JPMorgan Chase & Co. - MarketBeat
(QURE) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
uniQure N.V. (UQ1) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Smart Money Is Betting Big In QURE Options - Benzinga
Can uniQure N.V. stock sustain institutional interestDip Buying & Stock Portfolio Risk Management - Newser
Will uniQure N.V. (UQ1) stock draw ESG focused fundsQuarterly Growth Report & Long-Term Capital Growth Ideas - Newser
How uniQure N.V. stock performs in weak economy2025 Stock Rankings & AI Forecasted Stock Moves - Newser
Will uniQure N.V. (UQ1) stock sustain uptrend momentumJuly 2025 Momentum & Community Consensus Picks - Newser
Can uniQure N.V. (UQ1) stock sustain revenue momentumWeekly Profit Report & Detailed Earnings Play Strategies - Newser
uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences - MSN
ETF Watch: How strong is uniQure NV stock revenue growthJuly 2025 Rallies & Stock Portfolio Risk Management - BỘ NỘI VỤ
Wall Street Zen Upgrades uniQure (NASDAQ:QURE) to Hold - MarketBeat
uniQure N.V. (QURE) Options Chain - Yahoo! Finance Canada
How uniQure N.V. stock benefits from tech adoptionEarnings Growth Report & Expert Curated Trade Setups - BỘ NỘI VỤ
uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results - MSN
William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty - MSN
uniQure N.V. (NASDAQ:QURE) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is uniQure N.V. stock positioned for long term growthQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - moha.gov.vn
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - Your Wyoming Link
Franklin Resources Inc. Has $22.38 Million Stock Position in uniQure N.V. $QURE - MarketBeat
How sustainable is uniQure N.V. stock dividend payoutJuly 2025 Opening Moves & Stepwise Trade Signal Guides - moha.gov.vn
Market Pulse: Can uniQure N.V. stock surprise with earnings upsideWeekly Investment Report & Technical Entry and Exit Tips - BỘ NỘI VỤ
uniQure put volume heavy and directionally bearish - TipRanks
Uniqure N V Azioni (QURE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.44%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):